Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-06-042802
Filing Date
2006-10-19
Accepted
2006-10-18 20:23:32
Documents
8
Period of Report
2006-10-31

Document Format Files

Seq Description Document Type Size
1 v055131_6k.htm 6-K 169021
2 GRAPHIC logo1.jpg GRAPHIC 19060
3 GRAPHIC logo2.jpg GRAPHIC 50505
4 GRAPHIC pg7.jpg GRAPHIC 208670
5 GRAPHIC pg8-1.jpg GRAPHIC 4331
6 GRAPHIC pg8-2.jpg GRAPHIC 28297
7 GRAPHIC sig1.jpg GRAPHIC 21126
8 GRAPHIC sig2.jpg GRAPHIC 20953
  Complete submission text file 0001144204-06-042802.txt   657534
Mailing Address
Business Address LEVEL 1 100 DORCAS STREET SOUTH MELBOURNE VIC 3205 AUSTRALIA VICTORIA C3 00000 01161396908537
PRANA BIOTECHNOLOGY LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 061151890
SIC: 2834 Pharmaceutical Preparations